Yuichiro Inagaki

Anjo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Fatal differentiation syndrome-associated myocarditis caused by PML: RARα-positive neutrophils in acute promyelocytic leukemia.

Fatal differentiation syndrome-associated myocarditis caused by PML: RARα-positive neutrophils in acute promyelocytic leukemia.

Journal: Leukemia & lymphoma
Published: August 06, 2026

Morphologic Leukemia-Free State after Venetoclax-Based Therapy in Acute Myeloid Leukemia is Associated with High Relapse Despite Preserved Short-Term Survival.

Morphologic Leukemia-Free State after Venetoclax-Based Therapy in Acute Myeloid Leukemia is Associated with High Relapse Despite Preserved Short-Term Survival.

Journal: Mediterranean journal of hematology and infectious diseases
Published: April 22, 2026

Vaccine-Induced Anti-HBs Response is Associated with Protection Against Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Cell Transplantation: A Randomized Trial.

Vaccine-Induced Anti-HBs Response is Associated with Protection Against Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Cell Transplantation: A Randomized Trial.

Journal: Transplantation and cellular therapy
Published: March 13, 2026

Intermediate-dose cytarabine as a safer consolidation strategy for acute myeloid leukemia.

Intermediate-dose cytarabine as a safer consolidation strategy for acute myeloid leukemia.

Journal: International journal of hematology
Published: August 22, 2025

Percentage of CD56+ monocytes at neutrophil engraftment is associated with the incidence of acute graft-versus-host disease.

Percentage of CD56+ monocytes at neutrophil engraftment is associated with the incidence of acute graft-versus-host disease.

Journal: Annals of hematology
Published: July 01, 2025

The Impact of Tirabrutinib Monotherapy for the Treatment of Bing-Neel Syndrome: A Multicenter Retrospective Study.

The Impact of Tirabrutinib Monotherapy for the Treatment of Bing-Neel Syndrome: A Multicenter Retrospective Study.

Journal: American journal of hematology
Published: March 10, 2025

Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter study.

Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter study.

Journal: Cytotherapy
Published: February 17, 2025

Clinical profile and risk factors of low percent vital capacity after allogeneic hematopoietic stem cell transplantation.

Clinical profile and risk factors of low percent vital capacity after allogeneic hematopoietic stem cell transplantation.

Journal: Cytotherapy
Published: January 15, 2025

Post-transplant TKIs for Ph+ ALL: practices to date and clinical significance.

Post-transplant TKIs for Ph+ ALL: practices to date and clinical significance.

Journal: International journal of hematology
Published: November 18, 2024

Letermovir improves the outcome of allogenic stem cell transplantation with anti-thymocyte globulin against acute leukemia and myelodysplastic syndromes.

Letermovir improves the outcome of allogenic stem cell transplantation with anti-thymocyte globulin against acute leukemia and myelodysplastic syndromes.

Journal: Annals of hematology
Published: June 05, 2024

Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia.

Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia.

Journal: Journal of hematology
Published: May 26, 2024

Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation.

Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation.

Journal: International journal of hematology
Published: April 27, 2023
Showing 1-12 of 28

Last Updated: 09/26/2026